ETF Holdings Breakdown of KROS

Stock NameKeros Therapeutics Inc
TickerKROS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4923271013

News associated with KROS

Keros Therapeutics, Inc. (NASDAQ:KROS) Position Increased by CANADA LIFE ASSURANCE Co
CANADA LIFE ASSURANCE Co increased its stake in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 207.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,371 shares of the company’s stock after purchasing an additional 4,976 shares during the period. […] - 2025-05-01 08:40:59
Keros Therapeutics, Inc. (NASDAQ:KROS) Shares Sold by Russell Investments Group Ltd.
Russell Investments Group Ltd. reduced its stake in shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 67.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 33,321 shares of the company’s stock after selling 68,995 shares during the quarter. Russell Investments […] - 2025-04-24 07:44:48
Geode Capital Management LLC Buys 39,815 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS)
Geode Capital Management LLC raised its position in shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) by 5.5% during the fourth quarter, HoldingsChannel reports. The fund owned 765,436 shares of the company’s stock after acquiring an additional 39,815 shares during the quarter. Geode Capital Management LLC’s holdings in Keros Therapeutics were worth $12,120,000 at […] - 2025-04-22 08:13:07
KLP Kapitalforvaltning AS Invests $90,000 in Keros Therapeutics, Inc. (NASDAQ:KROS)
KLP Kapitalforvaltning AS purchased a new stake in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,700 shares of the company’s stock, valued at approximately $90,000. A number of other hedge funds […] - 2025-04-11 08:40:58
Wedbush Reiterates “Neutral” Rating for Keros Therapeutics (NASDAQ:KROS)
Keros Therapeutics (NASDAQ:KROS – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Wedbush in a research note issued on Tuesday,Benzinga reports. They presently have a $15.00 target price on the stock. Wedbush’s target price would suggest a potential upside of 49.40% from the stock’s previous close. Several other equities analysts […] - 2025-04-03 07:34:50
Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) Target Price at $42.33
Shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen analysts that are presently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average […] - 2025-04-02 08:03:11
Brokerages Set Keros Therapeutics, Inc. (NASDAQ:KROS) Price Target at $52.56
Shares of Keros Therapeutics, Inc. (NASDAQ:KROS – Get Free Report) have received an average recommendation of “Moderate Buy” from the fourteen research firms that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price […] - 2025-02-11 08:30:53

KROS institutional holdings

The following institutional investment holdings of KROS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-02-27 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 20,148USD 221,829 0.6%
2025-02-27 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 19,999USD 220,189 0.6%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 18,406USD 258,052
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 18,406USD 258,052 2.2%
2024-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 360USD 23,357
Total =77,319 USD 981,479
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.